Evidence map›Paper›PMID 40084880›Full record

ArticleAntimicrobial agents and chemotherapy2025

Triple antimicrobial combinations with potent synergistic activity against

Yanqin Huang, Lucius Chiaraviglio, Ibidunni Bode-Sojobi, James E Kirby

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Antimicrobial Resistance: The Answers.British journal of biomedical science · 2026
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Yanqin HuangHarvard Medical School, Boston, Massachusetts, USA.
Lucius ChiaraviglioDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Ibidunni Bode-SojobiHarvard Medical School, Boston, Massachusetts, USA.
James E KirbyHarvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-0392-4500

Funding

INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Academy of Clinical Laboratory Physicians and Scientists Paul E. Strandjord Young Investigator Research GrantMassachusetts Life Sciences Center Novel Therapeutics Delivery GrantNational Institute of Allergy and Infectious Diseases T32AI007061NIAID NIH HHS T32 AI007061
6 · The paper itself

Abstract

Synergy of antimicrobial combinations was tested against contemporary

Indexed as

Anti-Bacterial AgentsMycobacterium abscessusAzithromycinClofazimineDrug CombinationsDrug SynergismHumansLinezolidMicrobial Sensitivity TestsTetracyclinesTigecyclineAnti-Bacterial AgentsAzithromycinClofazimineDrug CombinationsLinezolidomadacyclineTetracyclinesTigecyclineazithromycinclofaziminecontezolidlinezolidmacrolideMycobacteroides abscessusnon-tuberculous mycobacteriumomadacyclinesynergytherapeutics checkerboardtigecycline

Identifiers

PMID40084880
PMCPMC11963555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.